Matthew James Pianko MD (He/Him)
Hematologic Oncology
Clinical Associate Professor - University of Michigan
Join to View Full Profile
1500 E. Medical Center Dr.C342 Med Inn Bldg, SPC 5848Ann Arbor, MI 48109
Phone+1 734-647-0118
Dr. Pianko is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Clinical Expertise
- Hematology, Hematologic oncology, Medical oncology, Immunotherapy
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2015 - 2018
New York Presbyterian Hospital (Columbia Campus)Residency, Internal Medicine, 2011 - 2014
Stanford University School of MedicineClass of 2011
Certifications & Licensure
MI State Medical License 2018 - 2028
NY State Medical License 2012 - 2018
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Mortimer P. Lacher Fellow The Lymphoma Foundation of MSKCC, 2017-2018
- Humanism and Excellence in Teaching Award Arnold P. Gold Foundation, 2013
Clinical Trials
- S1803, Lenalidomide +/- Daratumumab/rHuPh20 as Post-ASCT Maintenance for MM w/MRD to Direct Therapy Duration Start of enrollment: 2019 Aug 13
Publications & Presentations
PubMed
- Predictors of frontline doublet or triplet regimen initiation in transplant-ineligible newly diagnosed multiple myeloma.Matthew J Pianko, Niodita Gupta-Werner, Bruno Emond, Patrick Lefebvre, Marie-Hélène Lafeuille
Future Science OA. 2025-12-01 - Refining renal response assessment in monoclonal immunoglobulin deposition disease: Challenges, limitations and need for consensus.Sabine Karam, Matthew J Pianko, Hani Hassoun
Leukemia. 2025-09-01 - Frailty measures in multiple myeloma: evaluating the impact on outcomes and quality-of-life in clinical trials and real-world practice.Matthew J Pianko, Hira S Mian, Kelly L Schoenbeck, Tanya M Wildes
Leukemia & Lymphoma. 2025-02-01
Press Mentions
COVID-19 Update: Casinos Get Reopening Rules but No Start Date, Hospitality Group Publishes Guidelines, and MoreJune 9th, 2020
Professional Memberships
- Member
- Member
- Member
- Society for Immunotherapy of CancerMember
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
